Antiva Biosciences, Inc. — Form D

Antiva Biosciences, Inc. of Redwood City, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-03-06. The offering totals $1.0M, of which $501K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (41)

Showing 25 of 41 people.

NameRoleLocation
David P KabakoffDirectorBeltsville, MD
Steven JamesDirectorREDWOOD CITY, CA
Clifford SamuelDirectorRedwood City, CA
Beni RovinskiDirectorRedwood City, CA
Florencia SegalDirectorRedwood City, CA
Gail MaderisDirectorRedwood City, CA
Gail MaderisExecutive OfficerRedwood City, CA
Kristine BallDirectorRedwood City, CA
Kristine BallExecutive OfficerRedwood City, CA
Elaine ChienExecutive OfficerRedwood City, CA
Brian GoodmanDirectorRedwood City, CA
Wende HuttonDirectorMenlo Park, CA
Sarah WalterExecutive OfficerRedwood City, CA
Raju GadirajuExecutive OfficerRedwood City, CA
Michael CannonDirectorEmeryville, CA
Oranee DanielsExecutive OfficerBRISBANE, CA
Jenny YipDirectorBRISBANE, CA
Benjamin RovinskiDirectorMendham, NJ
Vinzenz PloererDirectorBrisbane, CA
David KabakoffDirectorBrisbane, CA
Michael D CannonDirectorEmeryville, CA
John W SaywardExecutive OfficerSuwanee, GA
Vinzenz P PloererDirectorCambridge, MA
Steven P JamesDirectorSouth San Francisco, CA
David P Kabakoff, Ph.D.DirectorSouth San Francisco, CA

Other filings by this issuer (10)

FiledFormOfferingSold
2024-10-11D/A$53.0M$38.5M
2023-05-05D$53.0M$26.6M
2021-11-03D$31.0M$15.6M
2018-07-19D$15.0M$15.0M
2017-08-28D/A$25.9M$14.7M
2017-04-05D$22.3M$11.1M
2015-06-11D$16.0M$8.9M
2014-12-23D$2.5M$1.7M
2014-07-10D$1.3M$1.1M
2013-09-05D/A$1.1M$1.1M

More